SOMATULINE Trademark

Trademark Overview

On Tuesday, August 31, 1999, a trademark application was filed for SOMATULINE with the United States Patent and Trademark Office. The USPTO has given the SOMATULINE trademark a serial number of 75789007. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, April 8, 2022. This trademark is owned by Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S). The SOMATULINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of neuro-endocrine tumors
somatuline

General Information

Serial Number75789007
Word MarkSOMATULINE
Filing DateTuesday, August 31, 1999
Status800 - REGISTERED AND RENEWED
Status DateFriday, April 8, 2022
Registration Number2524021
Registration DateTuesday, January 1, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2001

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of neuro-endocrine tumors
Pseudo MarkSOMA TULINE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 1, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S.
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressBoulogne Billancourt 92100
FR
Party NameSociete de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75781
FR
Party NameSociete de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75016 Paris
FR
Party NameSociete de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75016 Paris
FR

Trademark Events

Event DateEvent Description
Wednesday, August 23, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 8, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, April 8, 2022REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, April 8, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, April 8, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 14, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 14, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 6, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, January 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 10, 2021TEAS SECTION 8 & 9 RECEIVED
Friday, January 1, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, June 22, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, May 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 29, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, May 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 31, 2011REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, December 31, 2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, December 31, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 1, 2011TEAS SECTION 8 & 9 RECEIVED
Wednesday, April 1, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 3, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, December 28, 2007ASSIGNED TO PARALEGAL
Friday, December 21, 2007TEAS SECTION 8 RECEIVED
Monday, April 23, 2007CASE FILE IN TICRS
Friday, May 20, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 1, 2002REGISTERED-PRINCIPAL REGISTER
Friday, October 26, 2001Sec. 1(B) CLAIM DELETED
Friday, October 26, 2001NOTICE OF ALLOWANCE CANCELLED
Tuesday, July 3, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2001PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2001NOTICE OF PUBLICATION
Friday, September 29, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 11, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 24, 2000NON-FINAL ACTION MAILED
Wednesday, December 15, 1999ASSIGNED TO EXAMINER

Related Keywords

somatuline endocrine tumors neuro treatment preparations pharmaceutical